Tekla Healthcare Investors


Tekla Healthcare Investors

FinancialsClosed End Investments
  • Price (USD)18.65
  • Today's Change0.06 / 0.32%
  • Shares traded81.42k
  • 1 Year change-21.97%
  • Beta0.8431
Data delayed at least 15 minutes, as of Nov 25 2022 18:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Tekla Healthcare Investors is a non-diversified closed-end healthcare fund. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare, healthcare technology, and healthcare facilities. Tekla Capital Management LLC is the investment adviser of the Fund.

  • Revenue in USD (TTM)7.17m
  • Net income in USD-48.44m
  • Incorporated1986
  • Employees--
  • Location
    Tekla Healthcare Investors100 Federal Street, 19Th FloorBOSTON 02109-4884United StatesUSA
  • Phone+1 (617) 772-8515
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
MidCap Financial Investment Corp222.00m46.43m818.14m0.0017.290.8092--3.690.72280.72283.4715.450.0845--23.57--1.771.861.801.9149.2256.6120.9219.42--1.950.5981240.49-1.66-5.30-26.3735.00---10.00
John Hancock Tax-Advantage Dvd Incom Fd.-100.00bn-100.00bn824.89m0.00------------------------------------------------------------
Winmark Corporation80.66m40.84m831.63m85.0021.59--20.1110.3111.2011.2022.14-17.571.826.8953.27948,934.1092.0868.50123.2489.9095.5396.4750.6343.101.7720.805.3535.3218.403.2933.8512.50-59.5934.02
Tekla Healthcare Opportunities Fund19.91m111.97m854.00m--7.630.8654--42.892.712.710.481523.860.0168--4.82--9.428.469.448.6020.2026.50562.37406.84----0.185761.000.6156-0.85566.8817.05---3.93
Abrdn Total Dynamic Dividend Fund-100.00bn-100.00bn859.26m--------------------------------------------------------------
Apollo Strategic Growth Capital II0.0019.44m862.07m--46.991.31134.97--0.21270.21270.007.630.00------2.80--2.84--------------0.0075------606,982.70------
AllianceBernstein Global Hgh Incm Fd Inc-100.00bn-100.00bn863.16m0.00------------------------------------------------------------
Longview Acquisition Corp II0.0025.25m864.23m--34.501.31----0.29050.29050.007.650.00------3.65--3.67--------------0.005------487,040.80------
Tekla Healthcare Investors7.17m-48.44m864.31m----0.8499--120.52-1.04-1.040.15521.940.0067--2.22---4.518.53-4.548.60-63.78-44.85-675.491,246.77---0.11040.0091.15-27.466.18-35.67------
Blackrock Muniyield Quality Fund Inc.-100.00bn-100.00bn864.77m----0.8502----------20.04----------------------------0.1255--------------
Pontem Corp0.0024.15m865.95m--35.861.31----0.28000.28000.007.690.00------3.49--3.49--------------0.0009------17,134.60------
Redwood Trust Inc696.72m-80.52m871.66m298.00--0.7551--1.25-0.6978-0.69785.5810.180.0532--6.432,337,990.00-0.57530.2768-0.68410.329325.6028.94-10.826.63--0.53150.9108365.430.526318.47152.9219.36---6.98
BlackRock Resources&Commdts Strtgy Trst181.80m48.80m875.21m--17.940.9961--4.810.55250.55252.069.950.2052--68.53--5.516.225.546.2494.7579.2326.84126.45--1.400.008597.06400.65--1,834.20-0.931---2.15
Eaton Vance Enhanced Equity Incme Fnd II9.02m-262.74m889.96m0.00--1.05--98.61-5.13-5.130.174116.550.0088--32.46---25.6817.92-26.1218.08-26.29-23.68-2,911.312,137.70---0.0110.0029.3624.93-0.4187-17.7468.09--4.99
Calamos Conv. Opptys. & Income Fund-100.00bn-100.00bn893.38m--------------------------------------------------------------
Brightspire Capital Inc428.98m122.59m913.07m55.007.480.65135.752.130.94630.94633.3310.870.0762--8.777,799,564.002.27-3.562.39-3.7593.1274.4129.80-53.27--1.910.7481--18.0220.6271.40------
Data as of Nov 25 2022. Currency figures normalised to Tekla Healthcare Investors's reporting currency: US Dollar USD

Institutional shareholders

12.37%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 20222.97m6.42%
RBC Capital Markets LLC (Investment Management)as of 30 Sep 2022587.22k1.27%
Needham Investment Management LLCas of 30 Sep 2022334.80k0.72%
LPL Financial LLCas of 30 Sep 2022320.25k0.69%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Sep 2022305.13k0.66%
Wells Fargo Clearing Services LLCas of 30 Sep 2022298.09k0.64%
Raymond James Financial Services Advisors, Inc.as of 30 Sep 2022287.98k0.62%
UBS Financial Services, Inc.as of 30 Sep 2022231.52k0.50%
Wolverine Asset Management LLCas of 30 Sep 2022211.07k0.46%
First Trust Advisors LPas of 30 Sep 2022184.68k0.40%
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.